Adults 18 to 80, any sex, with Aphasia. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
SRT Observational Learning AbilityPrimary· Study visit 1 or 2, AGL Observational task completed before rule-based AGL task. SRT Observational and AGL Observational task order counterbalanced
For the SRT observational learning task, responses are made via eye gaze into a visual area of interest (AOI). Reaction times (RTs) are recorded as the time between target onset and gaze fixation within the target AOI. A trial is considered incorrect if an eye fixation was made that does not correspond to the target AOI. RTs for correct trials are examined. Outlier RTs three standard deviations above the mean RT of each block are removed. A score of learning is computed by comparing RTs on the last (7th) sequenced block of trials with RTs on the following (8th) pseudorandomized block (Schwarb
Group
Value
95% CI
Characterization of Learning
-0.03
± 0.34
AGL Observational Learning AbilityPrimary· Study visit 1 or 2, AGL Observational task completed before rule-based AGL task. SRT Observational and AGL Observational task order counterbalanced
For the AGL Observational learning task, a percent accuracy score is computed for the test phase. Higher scores indicate better outcome.
Group
Value
95% CI
Characterization of Learning
50.08
± 12.19
AGL Rule-based Learning AbilityPrimary· Study visit 1 or 2, AGL Observational task completed before rule-based AGL task. SRT Observational and AGL Observational task order counterbalanced
For the rule-based AGL task, a percent accuracy score is computed for the test phase. Higher scores indicate better outcome.
Group
Value
95% CI
Characterization of Learning
63.1
± 21.6
Standardized Assessment of Cognitive Linguistic Ability - Language SeveritySecondary· Study visit 1 or 2
Standardized measure of severity of expressive and receptive language deficits (Western Aphasia Battery \[WAB\] score range 0 - 100 with high scores indicating lower severity)
Group
Value
95% CI
Characterization of Learning
80.5
± 13.8
Standardized Assessment of Cognitive Linguistic Ability - Cognitive Composite : AttentionSecondary· Study visit 1 or 2
Composite scores based on standardized assessments of attention, working memory, and executive function were computed. Each score is computed and reported as an percent score. Minimum score is 0, maximum is 100. Higher scores indicate better cognitive ability.
Group
Value
95% CI
Characterization of Learning
88.77
± 21.87
Standardized Assessment of Cognitive Linguistic Ability - Cognitive Composite : Working MemorySecondary· Study visit 1 or 2
Composite scores based on standardized assessments of attention, working memory, and executive function were computed. Each score is computed and reported as an percent score. Minimum score is 0, maximum is 100. Higher scores indicate better cognitive ability.
Group
Value
95% CI
Characterization of Learning
51.06
± 20.67
Standardized Assessment of Cognitive Linguistic Ability - Cognitive Composite : Executive FunctionSecondary· Study visit 1 or 2
Composite scores based on standardized assessments of attention, working memory, and executive function were computed. Each score is computed and reported as an percent score. Minimum score is 0, maximum is 100. Higher scores indicate better cognitive ability.
Group
Value
95% CI
Characterization of Learning
75.24
± 17.11
Percent Spared Tissue Per ROISecondary· Study visit 3, between one-month and five months from behavioral testing of learning
Lesion maps, in which the lesioned voxels are assigned a binary value (1 or 0), are normalized from native to the Montreal Neurological Institute (MNI) template (a standard brain template utilized in imaging studies). Individualized lesion maps are subtracted from each brain region of interest (ROI) to yield the volume of spared tissue per ROI. The percentage of spared tissue in each region is calculated by dividing the volume of spared tissue by the total volume of the MNI template atlas ROI. Two ROIs have been selected based on prior research showing differential activation in observational
Prefrontal cortex ROI
Group
Value
95% CI
Characterization of Learning
88.8
± 11.8
Striatum ROI
Group
Value
95% CI
Characterization of Learning
79.37
± 18.84
Sponsor's own description
Aphasia is an impairment in the expression or comprehension of language that results from stroke, traumatic brain injury or progressive neurological disease. Approximately two million people in the United States suffer from aphasia, which has profound impacts on quality of life, the ability to return to work and participation in life activities. Research has shown that speech-language therapy, the treatment for aphasia, can significantly improve people's ability to communicate. However, a major limitation in the field of aphasia rehabilitation is the lack of predictability in patients' response to therapy and the inability to tailor treatment to individuals. Currently, aphasia treatments are selected largely based on patient's language abilities and language deficits with little consideration of learning ability, which this study refers to as learning phenotype. Learning phenotype has been used to inform rehabilitation approaches in other domains but is not currently considered in aphasia. The overarching hypothesis of this work is that poor alignment of learning ability and language therapy limits progress for patients and presents a barrier to individualizing treatment.
The objectives of the proposed study are to (1) determine the learning phenotype of individuals with aphasia, and (2) examine how lesion characteristics (size and location of damage to the brain), language ability and cognitive ability relate to learning ability. To accomplish objectives, investigators propose to measure implicit (observational) and explicit (rule-based) learning ability in people with aphasia via computer-based tasks. Regression models will be used to examine brain and behavioral factors that relate to learning ability.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MGH Institute of Health Professions
Last refreshed: 10 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05119023.